March 17, 2015

Pharma Dynamics has entered into an agreement with Lupin, in which Lupin will acquire the remaining 40% equity in Pharma Dynamics.

March 17, 2015

Par Pharmaceutical Holdings last week announced that it filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. 

March 16, 2015

Healthiest You on Monday launched a healthcare price comparison app that helps ascertain the cost of procedures and pharmaceuticals. 

March 13, 2015

An Altarum report found that national health spending increased 5.7% in January 2015 vs. January 2014. 

March 12, 2015

CVS Health’s chief medical officer Troyen Brennan said in an interview with Reuters that the entry of copycat biotech drugs could cut prices of expensive medications by 40% to 50%.

March 11, 2015

A new MIT study published Wednesday suggests that a more powerful H1N1 influenza strain may be making its way through India. 

March 11, 2015

Mylan on Wednesday announced the launch of disulfiram tablets USP in dosage strengths of 250 mg and 500 mg.

March 11, 2015

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

March 10, 2015

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

March 10, 2015

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

March 10, 2015

The Food and Drug Administration recently published bio-equivalence guidance documents. 

March 10, 2015

Impax Labs completed its acquisition of Tower Holdings (which includes operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics. Impax also announced that it would reshape both the operating and reporting structure of its two divisions.

March 10, 2015

Teva Pharmaceuticals will sell its Sellersville, Penn., facility to G&W Labs. According to Teva, the move supports its mission of streamlining operations by reducing excess manufacturing capacity.

March 9, 2015

Apple on Monday better enabled medical research with the launch of open source software framework ResearchKit. 

March 2, 2015

Mylan on Friday announced the successful completion of the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

March 2, 2015

The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.

February 27, 2015

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

February 27, 2015

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 26, 2015

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

February 26, 2015

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

February 25, 2015

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday. 

February 24, 2015

The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change.